EVINE Live is a digital commerce company. The company provides a range of proprietary, exclusive and name-brand merchandise in the categories of jewelry and watches, home and consumer electronics, beauty and fashion and accessories directly to consumers via television, online and mobile devices. The company's television shopping network, Evine, provides entertaining content in a digital shopping experience 24 hours a day. The company also operates evine.com, a digital commerce platform that sells products which appear on the company's television shopping network as well as an extended assortment of online-only merchandise. The company's programming and products are also marketed via mobile devices and social media channels.

J.B. Hunt Transport Services is a holding company. Through its subsidiaries, the company is a surface transportation, delivery, and logistics company. The company's service offerings include transportation of full-truckload containerized freight, which it directly transports utilizing its equipment and company drivers or independent contractors. The company also provides customized freight movement, revenue equipment, labor, systems, and delivery services. The company's local and home delivery services typically are provided through a network of cross-dock service centers throughout the continental United States. The company's segments include Intermodal, Dedicated Contract Services?, Integrated Capacity Solutions, and Truckload.

National HealthCare is engaged in the operation of skilled nursing facilities, assisted living facilities, independent living facilities and homecare programs. The company's business activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. The company has a non-controlling ownership interest in a hospice care business that services the company-owned health care centers and others. In addition, the company provides management services, accounting and financial services, as well as insurance services to third party operators of health care facilities.

Novus Therapeutics is a pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat. The company has two platform technologies. The company's primary program (OP0201) is a surfactant-based nasal aerosol drug-device combination product candidate being developed as a treatment option for patients at risk for, or with, otitis media, which is middle ear inflammation and effusion with or without infection. The company also has a foam-based drug delivery technology platform (OP01xx), which may be developed to deliver drugs into the ear, nasal, and sinus cavities.

Nuvectra is a neurostimulation medical device company focused on the development and commercialization of its neurostimulation technology platform for the treatment of various disorders through stimulation of tissues associated with the nervous system. The company's neurostimulation technology platform has the potential to provide treatment to patients in several neurostimulation markets, including spinal cord stimulation (SCS), sacral neuromodulation, deep brain stimulation, and other emerging neurostimulation markets. The company's Algovita? SCS system (Algovita), is an application of its neurostimulation technology platform and is indicated for the treatment of chronic pain of the trunk and/or limbs.

Xencor is a clinical-stage biopharmaceutical company focused on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat diseases with unmet medical needs. The company is developing a suite of clinical-stage drug candidates from its proprietary XmAb? technology platforms that are designed to treat cancer and autoimmune diseases. The company's protein engineering knowledge and the XmAb technologies are focused on the parts of the antibody that interacts with various segments of the immune system and controls antibody structure. This segment, referred to as the Fc domain, is constant and interchangeable among antibodies.